Literature DB >> 29699077

Serum anti-Müllerian hormone level as a predictor of poor ovarian response in in vitro fertilization patients.

Sezai Sahmay1, Meral Cetin2, Pelin Ocal1, Semih Kaleli1, Hulya Senol1, Fatih Birol1, Tulay Irez1,3.   

Abstract

PURPOSE: To evaluate the clinical value of day 3 serum anti-Müllerian hormone (AMH) compared with day 3 serum follicle-stimulating hormone (FSH) and human chorionic gonadotropin (hCG) day estradiol (E2) levels and antral follicle count (AFC) in the prediction of poor ovarian response in controlled ovarian hyperstimulation (COH).
METHODS: AMH, FSH and AFC on day 3 as well as hCG day E2 levels were determined in 164 subjects. Receiver operating curve analyses and area under curves (AUC) of the study parameters were performed. Predictive values of the levels of day 3 AMH, FSH, AFC, and hCG day E2 as clinical parameters of ovarian response to COH were studied.
RESULTS: Thirty-eight women were defined as poor responders. The day 3 AMH and hCG day E2 levels and AFC of normal responders were significantly higher than those of the poor responders. In predicting poor response, the AUC of day 3 AMH level was significantly higher than that of day 3 FSH level but was similar to the hCG day E2 level. Day 3 AMH, FSH and hCG day E2 levels and AFC were found to predict a poor response. Day 3 AMH and hCG day E2 levels were more predictive compared with day 3 FSH level and AFC. The cut-off level of AMH was ≤2 with a sensitivity of 78.9% and a specificity of 73.8%.
CONCLUSION: Day 3 AMH has the ability to predict a poor response to COH and it is more predictive than day 3 FSH and AFC.

Entities:  

Keywords:  Anti‐Müllerian hormone; Antral follicle count; Follicle‐stimulating hormone; In vitro fertilization; Infertility; Intracytoplasmic sperm injection; Poor responders

Year:  2010        PMID: 29699077      PMCID: PMC5906898          DOI: 10.1007/s12522-010-0066-1

Source DB:  PubMed          Journal:  Reprod Med Biol        ISSN: 1445-5781


  27 in total

Review 1.  A systematic review of tests predicting ovarian reserve and IVF outcome.

Authors:  F J Broekmans; J Kwee; D J Hendriks; B W Mol; C B Lambalk
Journal:  Hum Reprod Update       Date:  2006-08-04       Impact factor: 15.610

2.  Inhibin A and inhibin B reflect ovarian function in assisted reproduction but are less useful at predicting outcome.

Authors:  J E Hall; C K Welt; D W Cramer
Journal:  Hum Reprod       Date:  1999-02       Impact factor: 6.918

3.  Early follicular antimüllerian hormone as an indicator of ovarian reserve.

Authors:  Cem Fiçicioglu; Tayfun Kutlu; Elif Baglam; Zeynep Bakacak
Journal:  Fertil Steril       Date:  2006-03       Impact factor: 7.329

4.  Anti-Müllerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology.

Authors:  A La Marca; S Giulini; A Tirelli; E Bertucci; T Marsella; S Xella; A Volpe
Journal:  Hum Reprod       Date:  2006-10-27       Impact factor: 6.918

5.  Prognostic assessment of female fecundity.

Authors:  D Navot; Z Rosenwaks; E J Margalioth
Journal:  Lancet       Date:  1987-09-19       Impact factor: 79.321

6.  Anti-Müllerian hormone levels and antral follicle count in women enrolled in in vitro fertilization cycles: relationship to lifestyle factors, chronological age and reproductive history.

Authors:  Luciano G Nardo; Dimitra Christodoulou; Della Gould; Steve A Roberts; Cheryl T Fitzgerald; Ian Laing
Journal:  Gynecol Endocrinol       Date:  2007       Impact factor: 2.260

Review 7.  Mullerian Inhibiting Substance is an ovarian growth factor of emerging clinical significance.

Authors:  David B Seifer; David T Maclaughlin
Journal:  Fertil Steril       Date:  2007-06-07       Impact factor: 7.329

8.  Exogenous follicle stimulating hormone ovarian reserve test (EFORT): a simple and reliable screening test for detecting 'poor responders' in in-vitro fertilization.

Authors:  R Fanchin; D de Ziegler; F Olivennes; J Taieb; A Dzik; R Frydman
Journal:  Hum Reprod       Date:  1994-09       Impact factor: 6.918

Review 9.  Clinical management of low ovarian response to stimulation for IVF: a systematic review.

Authors:  B C Tarlatzis; L Zepiridis; G Grimbizis; J Bontis
Journal:  Hum Reprod Update       Date:  2003 Jan-Feb       Impact factor: 15.610

10.  Correlation of antimüllerian hormone and baseline follicle-stimulating hormone levels.

Authors:  Tomer Singer; David H Barad; Andrea Weghofer; Norbert Gleicher
Journal:  Fertil Steril       Date:  2008-06-13       Impact factor: 7.329

View more
  1 in total

1.  Diagnosis of Polycystic Ovary Syndrome: AMH in combination with clinical symptoms.

Authors:  Sezai Sahmay; Yavuz Aydin; Mahmut Oncul; Levent M Senturk
Journal:  J Assist Reprod Genet       Date:  2013-12-18       Impact factor: 3.412

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.